Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Үндсэн зохиолчид: Xiang Tong (Зохиогч), Shijie Zhang (Зохиогч), Dongguang Wang (Зохиогч), Li Zhang (Зохиогч), Jizheng Huang (Зохиогч), Tianli Zhang (Зохиогч), Hong Fan (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...